Form 4: Alignment Healthcare President Dawn Maroney Sells Shares Under 10b5-1 Plan

Dawn Christine Maroney, President of Alignment Healthcare, sold shares of common stock on May 14, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Dawn Christine Maroney, President of Alignment Healthcare, sold shares of common stock on May 14, 2025.
• The sales were executed under a pre-arranged trading plan pursuant to Rule 10b5-1(c).
• A total of 22,164 shares were sold at a weighted average price of $14.7873, and 7,836 shares were sold at a weighted average price of $15.1214.
• Following the transactions, Maroney directly owns 2,102,899 shares of Alignment Healthcare common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating insider stock sales under a pre-arranged plan. It's a neutral event, neither particularly positive nor negative.

Industry Context

Sales by company insiders are a common occurrence and are often pre-planned to avoid accusations of insider trading. The use of a 10b5-1 plan allows insiders to sell shares at predetermined times and prices.

Stakeholder Impact

• The stock sale could have a minor negative impact on shareholder sentiment, but is unlikely to have a significant impact given the pre-planned nature of the transaction.

Key Dates

Keywords

Form 4, Alignment Healthcare, ALHC, Dawn Maroney, Stock Sale, 10b5-1 Plan, Insider Trading